MicroRNA profiling in cancerMUNKER, Reinhold; CALIN, George A.Clinical science (1979). 2011, Vol 121, Num 3-4, pp 141-158, issn 0143-5221, 18 p.Article

Potential Therapeutic Applications of miRNA-Based Technology in Hematological Malignancies : Innovative therapeutical approaches for hematological malignancies based on molecular target therapiesBARBAROTTO, Elisa; CALIN, George A.Current pharmaceutical design. 2008, Vol 14, Num 21, pp 2040-2050, issn 1381-6128, 11 p.Article

Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genesCALIN, George A; CROCE, Carlo M.Blood. 2009, Vol 114, Num 23, pp 4761-4770, issn 0006-4971, 10 p.Article

MicroRNAs and cancer : Profile, profile, profile : The Role of MicroRNAS in Human CancerBARBAROTTO, Elisa; SCHMITTGEN, Thomas D; CALIN, George A et al.International journal of cancer. 2008, Vol 122, Num 5, pp 969-977, issn 0020-7136, 9 p.Article

MicroRNA signatures in human cancersCALIN, George A; CROCE, Carlo M.Nature reviews. Genetics (Print). 2007, Num OCT, issn 1471-0056, S25-S34, SUPArticle

MicroRNAs and genomic variations: from Proteus tricks to Prometheus giftFABBRI, Muller; VALERI, Nicola; CALIN, George A et al.Carcinogenesis (New York. Print). 2009, Vol 30, Num 6, pp 912-917, issn 0143-3334, 6 p.Article

MicroRNAs : Fundamental facts and involvement in human diseasesDI LEVA, Gianpiero; CALIN, George A; CROCE, Carlo M et al.Birth defects research. Part C. Embryo today : reviews. 2006, Vol 78, Num 2, pp 180-189, 10 p.Article

MicroRNAs: Toward the Clinic for Breast Cancer Patients : MicroRNAs AND CANCER: FROM THE BENCH TO THE CLINICFERRACIN, Manuela; QUERZOLI, Patrizia; CALIN, George A et al.Seminars in oncology. 2011, Vol 38, Num 6, pp 764-775, issn 0093-7754, 12 p.Article

MICRORNA REGULATION OF IONIZING RADIATION-INDUCED PREMATURE SENESCENCEYONG WANG; SCHEIBER, Melissa N; NEUMANN, Carola et al.International journal of radiation oncology, biology, physics. 2011, Vol 81, Num 3, pp 839-848, issn 0360-3016, 10 p.Article

Polymorphisms in microRNA targets : a gold mine for molecular epidemiologyKEXIN CHEN; FENGJU SONG; CALIN, George A et al.Carcinogenesis (New York. Print). 2008, Vol 29, Num 7, pp 1306-1311, issn 0143-3334, 6 p.Article

MicroRNAs in the pathogeny of chronic lymphocytic leukaemiaNICOLOSO, Milena S; KIPPS, Thomas J; CROCE, Carlo M et al.British journal of haematology. 2007, Vol 139, Num 5, pp 709-716, issn 0007-1048, 8 p.Article

Emerging Roles of microRNAs in the Molecular Responses to Hypoxia : The Hypoxia-Inducible Factor (HIF) Pathway as a target for Prevention and Treatment of Clinical ManifestationsCROSBY, Meredith E; DEVLIN, Cecilia M; GLAZER, Peter M et al.Current pharmaceutical design (Print). 2009, Vol 15, Num 33, pp 3861-3866, issn 1381-6128, 6 p.Article

Levels of miR-29b do not predict for response in patients with acute myelogenous leukemia treated with the combination of 5-azacytidine, valproic acid, and ATRAHUI YANG; ZHIHONG FANG; YUE WEI et al.American journal of hematology. 2011, Vol 86, Num 2, pp 237-238, issn 0361-8609, 2 p.Article

OMiR: Identification of associations between OMIM diseases and microRNAsROSSI, Simona; TSIRIGOS, Aristotelis; AMOROSO, Antonio et al.Genomics (San Diego, Calif.). 2011, Vol 97, Num 2, pp 71-76, issn 0888-7543, 6 p.Article

Complex Patterns of Altered MicroRNA Expression during the Adenoma-Adenocarcinoma Sequence for Microsatellite-Stable Colorectal CancerBARTLEY, Angela N; HUI YAO; BARKOH, Bedia A et al.Clinical cancer research (Print). 2011, Vol 17, Num 23, pp 7283-7293, issn 1078-0432, 11 p.Article

Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinomaGRAMANTIERI, Laura; FERRACIN, Manuela; CROCE, Carlo M et al.Cancer research (Baltimore). 2007, Vol 67, Num 13, pp 6092-6099, issn 0008-5472, 8 p.Article

Genetic Polymorphisms in MicroRNA-Related Genes as Predictors of Clinical Outcomes in Colorectal Adenocarcinoma PatientsMOUBIN LIN; JIAN GU; HAWK, Ernest T et al.Clinical cancer research (Print). 2012, Vol 18, Num 14, pp 3982-3991, issn 1078-0432, 10 p.Article

Plasma MicroRNA 210 Levels Correlate With Sensitivity to Trastuzumab and Tumor Presence in Breast Cancer PatientsJUNG, Eun-Jung; SANTARPIA, Libero; PUSZTAI, Lajos et al.Cancer. 2012, Vol 118, Num 10, pp 2603-2614, issn 0008-543X, 12 p.Article

Circulating microRNAs let-7a and miR-16 predict progression-free survival and overall survival in patients with myelodysplastic syndromeZHUANG ZUO; CALIN, George A; DE PAULA, Henrique M et al.Blood. 2011, Vol 118, Num 2, pp 413-415, issn 0006-4971, 3 p.Article

Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181PEKARSKY, Yuri; SANTANAM, Urmila; CALIN, George A et al.Cancer research (Baltimore). 2006, Vol 66, Num 24, pp 11590-11593, issn 0008-5472, 4 p.Article

miR-124 Inhibits STAT3 Signaling to Enhance T Cell-Mediated Immune Clearance of GliomaJUN WEI; FEI WANG; WEI QIAO et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 13, pp 3913-3926, issn 0008-5472, 14 p.Article

MicroRNA Down-Regulated in Human Cholangiocarcinoma Control Cell Cycle Through Multiple Targets Involved in the G1/S CheckpointOLARU, Alexandru V; GHIAUR, Gabriel; GEORGIADES, Christos et al.Hepatology (Baltimore, Md.). 2011, Vol 54, Num 6, pp 2089-2098, issn 0270-9139, 10 p.Article

MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon AdenocarcinomaSCHETTER, Aaron J; SUET YI LEUNG; LIU, Chang-Gong et al.JAMA, the journal of the American Medical Association. 2008, Vol 299, Num 4, pp 425-436, issn 0098-7484, 12 p.Article

Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancerMIOTTO, Elena; SABBIONI, Silvia; LANZA, Giovanni et al.Cancer research (Baltimore). 2004, Vol 64, Num 22, pp 8156-8159, issn 0008-5472, 4 p.Article

Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell linesSEVIGNANI, Cinzia; CALIN, George A; CESARI, Rossano et al.Cancer research (Baltimore). 2003, Vol 63, Num 6, pp 1183-1187, issn 0008-5472, 5 p.Article